Drug Type Recombinant polypeptide |
Synonyms- |
Target |
Action- |
Mechanism thrombin inhibitors(Factor IIa inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cardiovascular Diseases | Discovery | - | 23 Dec 2021 | |
Cardiovascular Diseases | Discovery | - | 23 Dec 2021 | |
Hemic and Lymphatic Diseases | Discovery | - | 23 Dec 2021 | |
Hemic and Lymphatic Diseases | Discovery | - | 23 Dec 2021 | |
Infectious Diseases | Discovery | - | 23 Dec 2021 | |
Infectious Diseases | Discovery | - | 23 Dec 2021 | |
Inflammation | Discovery | - | 23 Dec 2021 | |
Inflammation | Discovery | - | 23 Dec 2021 | |
Overnutrition | Discovery | - | 23 Dec 2021 | |
Overnutrition | Discovery | - | 23 Dec 2021 |